BNBX - APPLIED DNA SCIENCES INC
0.7
-0.039 -5.529%
Share volume: 44,175
Last Updated: 03-06-2026
Business Services/Services – Research, Development, Testing Labs:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.74
-0.04
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 05-10-2024 | 08-08-2024 | 02-13-2025 | 02-13-2025 | 05-15-2025 | 08-14-2025 | 12-19-2025 | 02-12-2026 | |
| Assets | |||||||||
| Total Assets | 9.176 M | 16.690 M | 12.789 M | 15.971 M | 13.036 M | 9.935 M | 4.437 M | 20.697 M | |
| Current Assets | 4.365 M | 11.842 M | 8.048 M | 11.276 M | 8.430 M | 5.629 M | 2.238 M | 5.111 M | |
| Inventories | 335.943 K | 469.871 K | 438.592 K | 468.580 K | 348.866 K | 338.723 K | 84.102 K | 89.954 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.150 M | 10.442 M | 6.431 M | 9.294 M | 6.823 M | 4.728 M | 1.668 M | 2.451 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 367.821 K | 530.735 K | 553.233 K | 638.483 K | 683.887 K | 511.203 K | 242.720 K | 193.922 K | |
| Other Assets | 4.443 M | 4.317 M | 4.188 M | 4.056 M | 3.921 M | 3.795 M | 1.956 M | 15.392 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 9.176 M | 16.690 M | 12.789 M | 15.971 M | 13.036 M | 9.935 M | 4.437 M | 20.697 M | |
| Total liabilities | 9.351 M | 4.456 M | 3.821 M | 3.421 M | 2.811 M | 2.947 M | 2.496 M | 2.237 M | |
| Total current liabilities | 2.623 M | 3.026 M | 2.398 M | 2.387 M | 1.894 M | 2.036 M | 2.464 M | 2.205 M | |
| Accounts Payable | 2.050 M | 2.441 M | 1.793 M | 1.611 M | 1.410 M | 1.565 M | 2.258 M | 2.141 M | |
| Other liabilities | 5.850 M | 551.869 K | 544.716 K | 156.328 K | 39.037 K | 32.627 K | 31.837 K | 31.467 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 5.850 M | 551.869 K | 544.716 K | 156.328 K | 39.037 K | 32.627 K | 31.837 K | 31.467 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -48.148 K | 12.392 M | 9.143 M | 12.753 M | 10.460 M | 7.263 M | 2.305 M | 18.836 M | |
| Common stock | 308.208 M | 318.768 M | 318.815 M | 339.973 M | 364.903 M | 381.151 M | 381.465 M | 416.623 M | |
| Retained earnings | -308.256 M | -306.376 M | -309.673 M | -327.219 M | -354.443 M | -373.889 M | -379.160 M | -397.787 M |